Circulation, Vol 82, 1889-1899, Copyright © 1990 by American Heart Association
ME Rosenthal and ME Josephson
With the limitations of currently available modalities for treating
clinically important tachycardias, the role of implanted antitachycardia
devices will continue to expand. The challenge of the future will not only
involve continued technological advances but the socioeconomic impact of
this efficacious but expensive mode of therapy in an era of increasing
financial restraints. Further studies to definitively prove the efficacy of
more widespread use of antitachycardia device therapy will be needed.
ARTICLES
Current status of antitachycardia devices
Clinical Electrophysiology Laboratory, Hospital of the University of Pennsylvania, Philadelphia 19104.
This article has been cited by other articles:
![]() |
M. Gulizia, S. Mangiameli, S. Orazi, G. Chiaranda, G. Boriani, G. Piccione, N. DiGiovanni, A. Colletti, C. Puntrello, G. Butera, et al. Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device Europace, July 1, 2006; 8(7): 465 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Arenal, J. Almendral, J. Villacastin, R. Morris, E. Castellanos, and J. L. Delcan First Postpacing Interval Variability During Right Ventricular Stimulation : A Single Algorithm for the Differential Diagnosis of Regular Tachycardias Circulation, August 18, 1998; 98(7): 671 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Davidson, L. D. Dugan, J. H. Burns, J. Bova, K. Story, and K. B. Drennan The Hypocholesterolemic Effects of {beta}-Glucan in Oatmeal and Oat Bran: A Dose-Controlled Study JAMA, April 10, 1991; 265(14): 1833 - 1839. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |